The Charcot foot in diabetes

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 2123-2129

  Rogers, Lee C ^a   Frykberg, Robert G ^b   Armstrong, David G ^c   Boulton, Andrew J M ^d   Edmonds, Michael ^e   Ha Van, Georges ^f   Hartemann, Agnes ^f   Game, Frances ^g   Jeffcoate, William ^g   Jirkovska, Alexandra ^h   Jude, Edward ^d   Morbach, Stephan ⁱ   Morrison, William B ^j   Pinzur, Michael ^k   Pitocco, Dario ^l   Sanders, Lee ^m   Wukich, Dane K ⁿ   Uccioli, Luigi ^o  

^a Valley Presbyterian Hospital   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^h INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

ⁱ Marienkrankenhaus ^*  (Germany)

^j THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^k LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^l CATHOLIC UNIVERSITY   (Italy)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^o UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ANKLE FOOT ORTHOSIS; ARTHRODESIS; BONE SCINTISCANNING; BRACE; CAST APPLICATION; CHARCOT FOOT; CLINICAL FEATURE; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ELECTROSTIMULATION THERAPY; FOOT RADIOGRAPHY; FRACTURE; FRACTURE IMMOBILIZATION; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; NEUROPATHY; NOMENCLATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SHOE; OSTEOARTHROPATHY; OSTEOCLAST; OSTEOPENIA; OSTEOSYNTHESIS; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; ULTRASOUND THERAPY; ARTICLE; DIABETIC FOOT; FOOT; PATHOLOGY; RADIOGRAPHY;

DIABETIC FOOT; FOOT; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84859177989     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0844     Document Type: Review

References (82)

1. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005;366:2058-2061 (Pubitemid 41773381)
2. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008;473:139-146
3. Uccioli L, Sinistro A, Almerighi C, et al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care 2010;33:350-355
4. Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor kappaB ligand. Diabetologia 2008;51:1035-1040
5. Stevens MJ, Edmonds ME, Foster AV, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 1992;35:148-154
6. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-38
7. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-463 (Pubitemid 28104210)
8. Shapiro SA, Stansberry KB, Hill MA, et al. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complications 1998;12:147-153 (Pubitemid 28241439)
9. Baker N, Green A, Krishnan S, Rayman G. Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care 2007;30:3077-3079 (Pubitemid 350255249)
10. Jeffcoate WJ, Game FL. New theories on the causes of the Charcot foot in diabetes. In The Diabetic Charcot Foot: Principles and Management. Frykberg RG, Ed. Brooklandville, MD, Data Trace Publishing Company, 2010, p. 29-44
11. Herbst SA, Jones KB, Saltzman CL. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 2004;86:378-383 (Pubitemid 38559490)
12. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007;22:1317-1328 (Pubitemid 351339677)
13. Matricali GA, Bammens B, Kuypers D, Flour M, Mathieu C. High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation 2007;83:245-246 (Pubitemid 46185226)
14. Pitocco D, Zelano G, Gioffrè G, et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a casecontrol study. Diabetes Care 2009;32:1694-1697
15. Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg 2004;43:87-92 (Pubitemid 38881268)
16. Eichenholtz SN. Charcot Joints. Springfield, IL, Charles C. Thomas, 1966
17. Charcot J-M, Fere C. Affections osseuses et articulaires du pied chez les tabétiques (Pied tabétique). Archives de Neurologie 1883;6:305-319 [in French]
18. Cofield RH, Morrison MJ, Beabout JW. Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle 1983;4:15-22 (Pubitemid 13016075)
19. Johnson JT. Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am 1967;49:1-30
20. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997;14:357-363 (Pubitemid 27248015)
21. Henderson VE. Joint affections in tabes dorsalis. J Pathol 1905;10:211-264
22. Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P. The Charcot foot in diabetes: six key points. Am Fam Physician 1998;57:2705-2710 (Pubitemid 28280502)
23. Jeffcoate W. The causes of the Charcot syndrome. Clin Podiatr Med Surg 2008;25:29-42, vi (Pubitemid 350299818)
24. McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia 2000;43:481-484 (Pubitemid 30237957)
25. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetesmellitus (clinical study of 101 cases). Medicine (Baltimore) 1972;51:191-210
26. Sanders LJ, Frykberg RG. The Charcot foot (Pied de Charcot). In Levin and O'Neal's The Diabetic Foot. 7th ed. Bowker JH, Pfeifer MA, Eds. Philadelphia, Mosby Elsevier, 2007, p. 257-283
27. Morrison WB, Shortt CP, Ting AYI. Imaging of the Charcot foot. In The Diabetic Charcot Foot: Principles and Management. Frykberg RG, Ed. Brooklandville, MD, Data Trace Publishing Company, 2010, p. 65-84
28. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am 2002;40:1171-1192 (Pubitemid 35385626)
29. Morrison WB, Ledermann HP, Schweitzer ME. MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am 2001;9:603-613, xi (Pubitemid 32916097)
30. Larcos G, Brown ML, Sutton RT. Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy. AJR Am J Roentgenol 1991;157:527-531
31. Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998;39:346-350 (Pubitemid 28114530)
32. Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 2005;46:444-449 (Pubitemid 43093153)
33. Hopfner S, Krolak C, Kessler S, Tiling R. Preoperative imaging of Charcot neuroarthropathy. Does the additional application of 18F-FDG-PET make sense? Nuklearmedizin 2005;45:15-20 (Pubitemid 44070817)
34. Frykberg RG, Eneroth M. Principles of conservative management. In The Diabetic Charcot Foot: Principles and Management. Frykberg RG, Ed. Brooklandville, MD, Data Trace Publishing Company, 2010, p. 93-116
35. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev 1997;34:317-321 (Pubitemid 27300747)
36. Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005;28:551-554 (Pubitemid 40326230)
37. Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boulton AJ. Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc 2002;92:405-408 (Pubitemid 44178795)
38. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994;11:28-31 (Pubitemid 24040538)
39. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001;44:2032-2037 (Pubitemid 33124049)
40. Pitocco D, Ruotolo V, Caputo S, et al. Sixmonth treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 2005;28:1214-1215 (Pubitemid 40616640)
41. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM. Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 2004;43:285-289 (Pubitemid 39335777)
42. Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol 2010;162:1009-1020
43. Bem R, Jirkovská A, Fejfarová V, Skibová J, Jude EB. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006;29:1392-1394 (Pubitemid 44125943)
44. Molines L, Darmon P, Raccah D. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 2010;36:251-255
45. Ulbrecht JS, Wukich DK. The Charcot foot: medical and surgical therapy. Curr Diab Rep 2008;8:444-451
46. Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications 2009;23:409-426
47. Strauss E, Gonya G. Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res 1998;(349):132-138 (Pubitemid 28196556)
48. Hockenbury RT, Gruttadauria M, McKinney I. Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int 2007;28:971-976 (Pubitemid 47546053)
49. Petrisor B, Lau JT. Electrical bone stimulation: an overview and its use in high risk and Charcot foot and ankle reconstructions. Foot Ankle Clin 2005;10:609-620, vii-viii (Pubitemid 41627811)
50. Pinzur MS. Surgical management: history and general principles. In The Diabetic Charcot Foot: Principles and Management. Frykberg RG, Ed. Brooklandville, MD, Data Trace Publishing Company, 2010, p. 165-188
51. Dhawan V, Spratt KF, Pinzur MS, Baumhauer J, Rudicel S, Saltzman CL. Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int 2005;26:717-731 (Pubitemid 41279048)
52. Lavery LA, Armstrong DG, Boulton AJ; Diabetex Research Group. Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. J Am Podiatr Med Assoc 2002;92:479-482 (Pubitemid 44146390)
53. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998;80:365-369 (Pubitemid 28152859)
54. Hastings MK, Mueller MJ, Sinacore DR, Salsich GB, Engsberg JR, Johnson JE. Effects of a tendo-Achilles lengthening procedure on muscle function and gait characteristics in a patient with diabetes mellitus. J Orthop Sports Phys Ther 2000;30:85-90 (Pubitemid 30084492)
55. Maluf KS, Mueller MJ, Strube MJ, Engsberg JR, Johnson JE. Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech 2004;37:897-906 (Pubitemid 38521211)
56. Holstein P, Lohmann M, Bitsch M, Jørgensen B. Achilles tendon lengthening, the panacea for plantar forefoot ulceration? Diabetes Metab Res Rev 2004;20(Suppl. 1):S37-S40 (Pubitemid 38714334)
57. Mueller MJ, Sinacore DR, Hastings MK, Lott DJ, Strube MJ, Johnson JE. Impact of Achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer. Diabetes Care 2004;27:1559-1564 (Pubitemid 38857426)
58. Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg 2000;39:291-300
59. Rosenblum BI, Giurini JM, Miller LB, Chrzan JS, Habershaw GM. Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg 1997;36:360-363 (Pubitemid 27483867)
60. Laurinaviciene R, Kirketerp-Moeller K, Holstein PE. Exostectomy for chronic midfoot plantar ulcer in Charcot deformity. J Wound Care 2008;17:53-55, 57-58
61. Mittlmeier T, Klaue K, Haar P, Beck M. Should one consider primary surgical reconstruction in Charcot arthropathy of the feet? Clin Orthop Relat Res 2010;468:1002-1011
62. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg Am 2000;82-A:939-950 (Pubitemid 30451932)
63. Papa J, Myerson M, Girard P. Salvage, with arthrodesis, in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am 1993;75:1056-1066 (Pubitemid 23264266)
64. Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg 2002;91:195-201 (Pubitemid 34967034)
65. Stone NC, Daniels TR. Midfoot and hindfoot arthrodeses in diabetic Charcot arthropathy. Can J Surg 2000;43:449-455 (Pubitemid 32002429)
66. Pinzur M. Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int 2004;25:545-549 (Pubitemid 39096102)
67. Garapati R, Weinfeld SB. Complex reconstruction of the diabetic foot and ankle. Am J Surg 2004;187(5A):81S-86S (Pubitemid 38625993)
68. Assal M, Stern R. Realignment and extended fusion with use of amedial column screw for midfoot deformities secondary to diabetic neuropathy. J Bone Joint Surg Am 2009;91:812-820
69. Pinzur MS. Neutral ring fixation for highrisk nonplantigrade Charcot midfoot deformity. Foot Ankle Int 2007;28:961-966 (Pubitemid 47546051)
70. Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int 2002;23:130-134 (Pubitemid 34157732)
71. Fabrin J, Larsen K, Holstein PE. Arthrodesis with external fixation in the unstable or misaligned Charcot ankle in patients with diabetes mellitus. Int J Low Extrem Wounds 2007;6:102-107 (Pubitemid 46897215)
72. Wukich DK, Belczyk RJ, Burns PR, Frykberg RG. Complications encountered with circular ring fixation in persons with diabetesmellitus. Foot Ankle Int 2008;29:994-1000
73. Bevilacqua NJ, Rogers LC. Surgical management of Charcot midfoot deformities. Clin Podiatr Med Surg 2008;25:81-94, vii (Pubitemid 350299822)
74. Rogers LC, Bevilacqua NJ, Frykberg RG, Armstrong DG. Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle. J Foot Ankle Surg 2007;46:372-375 (Pubitemid 47302813)
75. Connolly JF, Csencsitz TA. Limb threatening neuropathic complications from ankle fractures in patients with diabetes. Clin Orthop Relat Res 1998;(348):212-219 (Pubitemid 28160826)
76. Jani MM, Ricci WM, Borrelli J Jr, Barrett SE, Johnson JE. A protocol for treatment of unstable ankle fractures using transarticular fixation in patients with diabetes mellitus and loss of protective sensibility. Foot Ankle Int 2003;24:838-844 (Pubitemid 37429803)
77. Perry MD, Taranow WS, Manoli A 2nd, Carr JB. Salvage of failed neuropathic ankle fractures: use of large-fragment fibular plating and multiple syndesmotic screws. J Surg Orthop Adv 2005;14:85-91
78. Wukich DK, Joseph A, Ryan M, Ramirez C, Irrgang JJ. Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int 2011;32:120-130
79. Ayoub MA. Ankle fractures in diabetic neuropathic arthropathy: can tibiotalar arthrodesis salvage the limb? J Bone Joint Surg Br 2008;90:906-914 (Pubitemid 352009779)
80. Dalla Paola L, Volpe A, Varotto D, et al. Use of a retrograde nail for ankle arthrodesis in Charcot neuroarthropathy: a limb salvage procedure. Foot Ankle Int 2007;28:967-970 (Pubitemid 47546052)
81. Caravaggi C, Cimmino M, Caruso S, Dalla Noce S. Intramedullary compressive nail fixation for the treatment of severe Charcot deformity of the ankle and rear foot. J Foot Ankle Surg 2006;45:20-24 (Pubitemid 43052982)
82. Pinzur MS, Noonan T. Ankle arthrodesis with a retrograde femoral nail for Charcot ankle arthropathy. Foot Ankle Int 2005;26:545-549 (Pubitemid 40944208)